Phio Pharmaceuticals Corp.
USD1.02
+0.04 (+4.06%)
CEO
Robert L. Bitterman
IPO Date
2012-05-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.02
Prev. Close
$0.98
Day Low
$1.01
Day High
$1.05
52W Low
$0.81
52W High
$4.19
Market Cap
$0.01B
Volume
0.22M
| 16,600 |
| $0.00 |
| 6 Feb 2026 | Freeman Jonathan E | director | A-Award | Acquired | 16,600 | $0.00 |
| 6 Feb 2026 | Deming David H | director | A-Award | Acquired | 23,800 | $0.00 |
| 6 Feb 2026 | Carson Lisa Cabott | Chief Financial Officer | A-Award | Acquired | 47,000 | $0.00 |
| 6 Feb 2026 | BRADFORD PATRICIA A | director | A-Award | Acquired | 18,500 | $0.00 |
| 6 Feb 2026 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | A-Award | Acquired | 120,000 | $0.00 |
| 2 Jan 2026 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | P-Purchase | Acquired | 5,000 | $1.03 |
| 29 Dec 2025 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | P-Purchase | Acquired | 5,000 | $1.02 |
| 24 Nov 2025 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | P-Purchase | Acquired | 5,000 | $1.14 |